1. [Chronic liver diseases--new therapy. Are biopsies necessary?].
- Author
-
Tannapfel A
- Subjects
- Comorbidity, Cooperative Behavior, Diagnosis, Differential, End Stage Liver Disease classification, End Stage Liver Disease diagnosis, End Stage Liver Disease etiology, Fatty Liver classification, Fatty Liver diagnosis, Fatty Liver etiology, Fatty Liver pathology, Guideline Adherence, Hemochromatosis classification, Hemochromatosis diagnosis, Hemochromatosis pathology, Hepatitis B, Chronic classification, Hepatitis B, Chronic diagnosis, Hepatitis B, Chronic pathology, Hepatitis C, Chronic classification, Hepatitis C, Chronic diagnosis, Hepatitis C, Chronic pathology, Hepatitis, Autoimmune classification, Hepatitis, Autoimmune diagnosis, Hepatitis, Autoimmune etiology, Hepatitis, Autoimmune pathology, Hepatolenticular Degeneration classification, Hepatolenticular Degeneration diagnosis, Hepatolenticular Degeneration genetics, Hepatolenticular Degeneration pathology, Humans, Interdisciplinary Communication, Predictive Value of Tests, Unnecessary Procedures, Biopsy, Needle, End Stage Liver Disease pathology, Liver pathology
- Abstract
Chronic liver disease can often reliably be assessed only by examination of biopsy material. In this article the possible indications for liver biopsy in viral hepatitis B and C, autoimmune liver disease, steatohepatitis and hereditary metabolic diseases are described. A biopsy may be useful in cases with unclear clinical or serological situations or with questionable chronicity and comorbidities. The assessment of biopsy material should be based on guideline-based classification systems. The value of biopsy diagnosis benefits from a close interdisciplinary clinical pathological cooperation.
- Published
- 2013
- Full Text
- View/download PDF